DANIELLE LINGO: Open Payments
NPI 1356888762 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 36 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $700 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $214 |
| Madrigal Pharmaceuticals | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $61 |
| Ardelyx, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| EVOKE PHARMA, INC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| GENZYME CORPORATION | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: RINVOQ, CREON, REZDIFFRA, XIFAXAN, TREMFYA, IBSRELA, GIMOTI, ZENPEP.
Industry payments across AL — which companies pay providers there.
